Report Detail
Global Personalized Medicine and Epigenomics Market Analysis 2020 with Top Companies, Production, Consumption,Price and Growth Rate
- RnM3951077 |
- 17 April, 2020 |
- Global |
- 127 Pages |
- XYZResearch |
- Chemical & Material
XYZ-research offers a comprehensive analysis of key market trends in the global Personalized Medicine and Epigenomics market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are backed by factful feedbacks.
Global markets continue to sink as the coronavirus spreads, reaching over 200 countries in total by the end of March. Now the outbreak continued to grow, as the number of cases in USA, Italy, Spain, Germany, France all spiked, Europe and USA have now become the epicenter of the outbreak, Cases in China appear have steadied in April, but there’s growing concern about the overall impact to the global market.
In China market, which experienced a difficult 2019 due to slowing domestic consumption and the impact of the Sino-US trade war, is once again facing more disruption and uncertainty at the hands of the coronavirus pandemic. Sales and consumption all fell in the first quarter of 2020, compared with the same period in 2019. The sales revenue of the major players will likely continue slowing in the 2nd quarter but in the second half of the year the fiscal and monetary policy would likely cause a strong rebound
In order to stop the spread of the COVID-19 outbreak, countries and world capital have been put under strict lockdown, bringing a total halt to major industrial production chains. It has caused supply chain disruptions for nearly three-quarters of U.S. companies, and in the second quarter, domestically consumption is likely to be hit even harder. The same situation also appeared in Europe, as the epidemic has required large-scale restrictions on the movement of people, investment, consumption and exports will all be strongly impacted by the epidemic, domestic production and consumption will plummet in the first half of 2020. We expected a U-shaped recovery in the second half of the year in USA and Europe market.
Brazil is already the hardest hit country in South America, many of these nations are still in the early stages of the virus’s proliferation. Infection levels have not yet peaked in April. South America 's market were on shaky ground even before the devastating impacts of the coronavirus, following a synchronized economic slowdown last year. China’s market downturn is impacting its trading partners in this region.
China, Japan, South Korea, India, and other Asia countries took the lead in introducing unprecedented measures to contain the virus, the market confidence in Asia-Pacific region is returning, EU and USA have relaxed its fiscal rules with maximum flexibility, this will stimulate the market demand in the second half of 2020.
Due to delays in the transport of components and raw materials, along with quarantine restrictions, the transportation of raw materials is affected, this will cause tight supply, and then the price of raw materials to rise. Meanwhile, as end-user demand weakens, many players are also facing the risk of higher inventory backlog, which may lead to passive production reduction, some traditional retailers began to develop the online business.
This report extensively provides a quantitative analysis of the industry from 2014-2026 based on the current international situation, by Region, Type, Application. Consumption assessment by application, production by type in different regions. Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. The market size in terms of revenue (USD) and production is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints). The worldwide market for Personalized Medicine and Epigenomicsmarket will reach xxx Million USD in 2020 and is expected to grow at a CAGR of xx% 2021-2026.
Geographically, global Personalized Medicine and Epigenomics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Abbott Laboratories
Affymetrix
Agilent Technologies
Astellas Pharmaceuticals
BAYER AG
Bio Vision
Celgene Corp.
Emd Millipore
Epigenomics AG
Epigentex
Envivo Pharmaceuticals (Forum Pharmaceutricals)
Gilead Sciences
Glaxosmithkline
Illumina Inc.
Johnson & Johnson
Karus Therapeutics Limited
Laboratory Corp. Of America Holdings
LES Laboratoires Servier
Merck
Naturewise Biotech & Medicals Corp.
Novartis Pharma AG
Oncolys Biopharma Inc.
Orchid Chemicals & Pharmaceuticals Limited
Progen Pharmaceuticals Limited
Quest Diagnostics
On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Reagents
Kits
Instruments
Enzymes
Services
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Personalized Medicine and Epigenomics for each application, including
Oncology
Non-Oncology
Cancer Drug Technology
Production, consumption, revenue, market share and growth rate are the key targets for Personalized Medicine and Epigenomics from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
- 1.1 Definition
- 1.2 Manufacturers and Regions Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.3 Type Overview
- 1.4 Application Overview
- 1.5 Industrial Chain
- 1.5.1 Personalized Medicine and Epigenomics Overall Industrial Chain
- 1.5.2 Upstream
- 1.5.3 Downstream
- 1.5.4 Economic/Political Environment
2 Global Personalized Medicine and Epigenomics Market Assesment by Types
- 2.1 Overall Market Performance
- 2.1.1 Product Type Market Performance (Volume)
- 2.1.2 Product Type Market Performance (Value)
- 2.2 China Personalized Medicine and Epigenomics Market Performance
- 2.3 USA Personalized Medicine and Epigenomics Market Performance
- 2.4 Europe Personalized Medicine and Epigenomics Market Performance
- 2.5 Japan Personalized Medicine and Epigenomics Market Performance
- 2.6 Korea Personalized Medicine and Epigenomics Market Performance
- 2.7 India Personalized Medicine and Epigenomics Market Performance
- 2.8 Southeast Asia Personalized Medicine and Epigenomics Market Performance
- 2.9 South America Personalized Medicine and Epigenomics Market Performance
3 Global Personalized Medicine and Epigenomics Market Assesment by Application
- 3.1 Overall Market Performance (Volume)
- 3.2 China Personalized Medicine and Epigenomics Market Performance (Volume)
- 3.3 USA Personalized Medicine and Epigenomics Market Performance (Volume)
- 3.4 Europe Personalized Medicine and Epigenomics Market Performance (Volume)
- 3.5 Japan Personalized Medicine and Epigenomics Market Performance (Volume)
- 3.6 Korea Personalized Medicine and Epigenomics Market Performance (Volume)
- 3.7 India Personalized Medicine and Epigenomics Market Performance (Volume)
- 3.8 Southeast Asia Personalized Medicine and Epigenomics Market Performance (Volume)
- 3.9 South America Personalized Medicine and Epigenomics Market Performance (Volume)
4 Competitive Analysis
- 4.1 Abbott Laboratories
- 4.1.1 Abbott Laboratories Profiles
- 4.1.2 Abbott Laboratories Product Information
- 4.1.3 Abbott Laboratories Personalized Medicine and Epigenomics Production, Revenue, Price and Gross Margin
- 4.1.4 Abbott Laboratories Personalized Medicine and Epigenomics Business Performance
- 4.1.5 SWOT Analysis
- 4.2 Affymetrix
- 4.2.1 Affymetrix Profiles
- 4.2.2 Affymetrix Product Information
- 4.2.3 Affymetrix Personalized Medicine and Epigenomics Production, Revenue, Price and Gross Margin
- 4.2.4 Affymetrix Personalized Medicine and Epigenomics Business Performance
- 4.2.5 SWOT Analysis
- 4.3 Agilent Technologies
- 4.3.1 Agilent Technologies Profiles
- 4.3.2 Agilent Technologies Product Information
- 4.3.3 Agilent Technologies Personalized Medicine and Epigenomics Production, Revenue, Price and Gross Margin
- 4.3.4 Agilent Technologies Personalized Medicine and Epigenomics Business Performance
- 4.3.5 SWOT Analysis
- 4.4 Astellas Pharmaceuticals
- 4.4.1 Astellas Pharmaceuticals Profiles
- 4.4.2 Astellas Pharmaceuticals Product Information
- 4.4.3 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Production, Revenue, Price and Gross Margin
- 4.4.4 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Business Performance
- 4.4.5 SWOT Analysis
- 4.5 BAYER AG
- 4.5.1 BAYER AG Profiles
- 4.5.2 BAYER AG Product Information
- 4.5.3 BAYER AG Personalized Medicine and Epigenomics Production, Revenue, Price and Gross Margin
- 4.5.4 BAYER AG Personalized Medicine and Epigenomics Business Performance
- 4.5.5 SWOT Analysis
- 4.6 Bio Vision
- 4.6.1 Bio Vision Profiles
- 4.6.2 Bio Vision Product Information
- 4.6.3 Bio Vision Personalized Medicine and Epigenomics Production, Revenue, Price and Gross Margin
- 4.6.4 Bio Vision Personalized Medicine and Epigenomics Business Performance
- 4.6.5 SWOT Analysis
- 4.7 Celgene Corp.
- 4.7.1 Celgene Corp. Profiles
- 4.7.2 Celgene Corp. Product Information
- 4.7.3 Celgene Corp. Personalized Medicine and Epigenomics Production, Revenue, Price and Gross Margin
- 4.7.4 Celgene Corp. Personalized Medicine and Epigenomics Business Performance
- 4.7.5 SWOT Analysis
- 4.8 Emd Millipore
- 4.8.1 Emd Millipore Profiles
- 4.8.2 Emd Millipore Product Information
- 4.8.3 Emd Millipore Personalized Medicine and Epigenomics Production, Revenue, Price and Gross Margin
- 4.8.4 Emd Millipore Personalized Medicine and Epigenomics Business Performance
- 4.8.5 SWOT Analysis
- 4.9 Epigenomics AG
- 4.9.1 Epigenomics AG Profiles
- 4.9.2 Epigenomics AG Product Information
- 4.9.3 Epigenomics AG Personalized Medicine and Epigenomics Production, Revenue, Price and Gross Margin
- 4.9.4 Epigenomics AG Personalized Medicine and Epigenomics Business Performance
- 4.9.5 SWOT Analysis
- 4.10 Epigentex
- 4.10.1 Epigentex Profiles
- 4.10.2 Epigentex Product Information
- 4.10.3 Epigentex Personalized Medicine and Epigenomics Production, Revenue, Price and Gross Margin
- 4.10.4 Epigentex Personalized Medicine and Epigenomics Business Performance
- 4.10.5 SWOT Analysis
- 4.11 Envivo Pharmaceuticals (Forum Pharmaceutricals)
- 4.12 Gilead Sciences
- 4.13 Glaxosmithkline
- 4.14 Illumina Inc.
- 4.15 Johnson & Johnson
- 4.16 Karus Therapeutics Limited
- 4.17 Laboratory Corp. Of America Holdings
- 4.18 LES Laboratoires Servier
- 4.19 Merck
- 4.20 Naturewise Biotech & Medicals Corp.
- 4.21 Novartis Pharma AG
- 4.22 Oncolys Biopharma Inc.
- 4.23 Orchid Chemicals & Pharmaceuticals Limited
- 4.24 Progen Pharmaceuticals Limited
- 4.25 Quest Diagnostics
5 Competitive Landscape
- 5.1 Global Personalized Medicine and Epigenomics Production (K Units) and Market Share by Manufacturers (2014-2020)
- 5.2 Global Personalized Medicine and Epigenomics Revenue (M USD) and Market Share by Manufacturers (2014-2020)
- 5.3 Global Personalized Medicine and Epigenomics Price (USD/Unit) of Manufacturers (2014-2020)
- 5.4 Global Personalized Medicine and Epigenomics Gross Margin of Manufacturers (2014-2020)
- 5.5 Market Concentration
6 Global Personalized Medicine and Epigenomics Market Assessment by Regions
- 6.1 Global Personalized Medicine and Epigenomics Production (K Units) and Market Share by Regions (2014-2020)
- 6.2 Global Personalized Medicine and Epigenomics Revenue (M USD) and Market Share by Regions (2014-2020)
- 6.3 Global Personalized Medicine and Epigenomics Price (USD/Unit) by Regions (2014-2020)
- 6.4 Global Personalized Medicine and Epigenomics Gross Margin by Regions (2014-2020)
7 Personalized Medicine and Epigenomics Regional Analysis
- 7.1 China Personalized Medicine and Epigenomics Production, Revenue and Growth Rate (2014-2020)
- 7.2 USA Personalized Medicine and Epigenomics Production, Revenue and Growth Rate (2014-2020)
- 7.3 Europe Personalized Medicine and Epigenomics Production, Revenue and Growth Rate (2014-2020)
- 7.4 Japan Personalized Medicine and Epigenomics Production, Revenue and Growth Rate (2014-2020)
- 7.5 Korea Personalized Medicine and Epigenomics Production, Revenue and Growth Rate (2014-2020)
- 7.6 India Personalized Medicine and Epigenomics Production, Revenue and Growth Rate (2014-2020)
- 7.7 Southeast Asia Personalized Medicine and Epigenomics Production, Revenue and Growth Rate (2014-2020)
- 7.8 South America Personalized Medicine and Epigenomics Production, Revenue and Growth Rate (2014-2020)
8 Global Personalized Medicine and Epigenomics Consumption Assessment
- 8.1 Global Personalized Medicine and Epigenomics Consumption and Market Share by Regions (2014-2020)
- 8.2 Global Personalized Medicine and Epigenomics Consumption Value and Market Share by Regions (2014-2020)
- 8.3 Global Personalized Medicine and Epigenomics Average Price (USD/Unit) by Regions (2014-2020)
9 Global Personalized Medicine and Epigenomics Sales Assessment by Regions
- 9.1 Global Personalized Medicine and Epigenomics Sales and Sales Value (2014-2020)
- 9.2 China Personalized Medicine and Epigenomics Sales and Sales Value (2014-2020)
- 9.3 USA Personalized Medicine and Epigenomics Sales and Sales Value (2014-2020)
- 9.4 Europe Personalized Medicine and Epigenomics Sales and Sales Value (2014-2020)
- 9.5 Japan Personalized Medicine and Epigenomics Sales and Sales Value (2014-2020)
- 9.6 Korea Personalized Medicine and Epigenomics Sales and Sales Value (2014-2020)
- 9.7 India Personalized Medicine and Epigenomics Sales and Sales Value (2014-2020)
- 9.8 Southeast Asia Personalized Medicine and Epigenomics Sales and Sales Value (2014-2020)
- 9.9 South America Personalized Medicine and Epigenomics Sales and Sales Value (2014-2020)
10 Technology and Cost
- 10.1 Technology
- 10.2 Cost
11 Channel Analysis
- 11.1 Market Channel
- 11.2 Distributors
12 Market Forecast 2021-2026
- 12.1 Production and Revenue Forecast 2021-2026
- 12.1.1 Global Personalized Medicine and Epigenomics Production and Revenue by Regions 2021-2026
- 12.1.2 China Personalized Medicine and Epigenomics Production, Revenue and Growth Rate 2021-2026
- 12.1.3 USA Personalized Medicine and Epigenomics Production, Revenue and Growth Rate 2021-2026
- 12.1.4 Europe Personalized Medicine and Epigenomics Production, Revenue and Growth Rate 2021-2026
- 12.1.5 Japan Personalized Medicine and Epigenomics Production, Revenue and Growth Rate 2021-2026
- 12.1.6 Korea Personalized Medicine and Epigenomics Production, Revenue and Growth Rate 2021-2026
- 12.1.7 India Personalized Medicine and Epigenomics Production, Revenue and Growth Rate 2021-2026
- 12.1.8 Southeast Asia Personalized Medicine and Epigenomics Production, Revenue and Growth Rate 2021-2026
- 12.1.9 South America Personalized Medicine and Epigenomics Production, Revenue and Growth Rate 2021-2026
- 12.2 Sales and Sales Value Forecast 2021-2026
- 12.2.1 Global Personalized Medicine and Epigenomics Consumption and Consumption Calue by Regions 2021-2026
- 12.2.2 Global Personalized Medicine and Epigenomics Sales and Sales Value Forecast 2021-2026
- 12.2.3 China Personalized Medicine and Epigenomics Sales, Sales Value and Growth Rate 2021-2026
- 12.2.4 USA Personalized Medicine and Epigenomics Sales and Sales Value Forecast 2021-2026
- 12.2.5 Europe Personalized Medicine and Epigenomics Sales and Sales Value Forecast 2021-2026
- 12.2.6 Japan Personalized Medicine and Epigenomics Sales and Sales Value Forecast 2021-2026
- 12.2.7 Korea Personalized Medicine and Epigenomics Sales and Sales Value Forecast 2021-2026
- 12.2.8 India Personalized Medicine and Epigenomics Sales and Sales Value Forecast 2021-2026
- 12.2.9 Southeast Asia Personalized Medicine and Epigenomics Sales and Sales Value Forecast 2021-2026
- 12.2.10 South America Personalized Medicine and Epigenomics Sales and Sales Value Forecast 2021-2026
- 12.3 Global Personalized Medicine and Epigenomics Production and Revenue Forecast by Type 2021-2026
- 12.3.1 Overall Market Performance
- 12.3.2 Reagents
- 12.3.3 Kits
- 12.3.4 Instruments
- 12.3.5 Enzymes
- 12.3.6 Services
- 12.4 Global Personalized Medicine and Epigenomics Sales Forecast by Application 2021-2026
- 12.4.1 Overall Market Performance
- 12.4.2 Oncology
- 12.4.3 Non-Oncology
- 12.4.4 Cancer Drug Technology
- 12.5 Global Personalized Medicine and Epigenomics Price and Gross Margin Forecast
- 13.5.1 Global Personalized Medicine and Epigenomics Averages Price Development Trend Forecast 2021-2026
- 13.5.2 Global Personalized Medicine and Epigenomics Gross Margin Development Trend Forecast 2021-2026
13 Conclusion
Summary:
Get latest Market Research Reports on Personalized Medicine and Epigenomics. Industry analysis & Market Report on Personalized Medicine and Epigenomics is a syndicated market report, published as Global Personalized Medicine and Epigenomics Market Analysis 2020 with Top Companies, Production, Consumption,Price and Growth Rate. It is complete Research Study and Industry Analysis of Personalized Medicine and Epigenomics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
